drugset / Trial / NCT03494387
VitamIn and oXygen Interventions and Cardiovascular Events
RandomizedFactorialDouble-blindPrevention
Summary
This study examines the risks and benefits of antioxidants and normal versus high inspiratory oxygen fraction during anaesthesia.
Timeline
- Start
- 2018-04-06
- Primary completion
- 2020-03-01
- Completion
- 2020-03-24
Outcome
Missed primary endpoint
paper HR 1.46 (95% CI, 0.79-2.70), p = 0.23. PMID 41055553 ↗
paper Antioxidants had a HR of 0.98 (95% CI, 0.54-1.80), p = 0.96 for all-cause mortality vs. placebo. PMID 41055553 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | N-acetylcysteine | Small molecule | 100 mg/kg | Intravenous |
| Subject | Oxygen | Other / unclassified | — | — |
| Subject | Vitamin C | Other / unclassified | 3 g | Intravenous |
Indications
No indication recorded.